Amikacin/rifampicinAcquired drug resistance: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1730卷 / 1期

关键词：

D O I：

10.1007/s40278-018-54926-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：26 / 26

相关论文

共 50 条

[41] ImatinibAcquired drug resistance and treatment failure: 2 case reports
Reactions Weekly, 2025, 2040 (1) : 445 - 445
[42] Multiple drugsCytomegalovirus encephalitis and drug resistance: 2 case reports
Reactions Weekly, 2020, 1796 (1) : 165 - 165
[43] Daclatasvir/ribavirin/sofosbuvirDevelopment of drug resistance: 2 case reports
Reactions Weekly, 2020, 1791 (1) : 87 - 87
[44] AntineoplasticsVarious toxicities and development of drug resistance: 2 case reports
Reactions Weekly, 2020, 1821 (1) : 39 - 39
[45] AntineoplasticsAcquired drug resistance and lack of efficacy : 2 case reports
Reactions Weekly, 2023, 1963 (1) : 58 - 58
[46] Dasatinib/imatinib/nilotinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2025, 2044 (1) : 118 - 118
[47] AntineoplasticsVomiting, drug resistance and lack of efficacy: 2 case reports
Reactions Weekly, 2021, 1878 (1) : 71 - 71
[48] Amikacin/Cefoperazone/sulbactam/CeftazidimeLack of efficacy : 2 case reports
Reactions Weekly, 2024, 2018 (1) : 32 - 32
[49] Amikacin/linezolidNeurosensorial hypoacusia and medullary hypoplasia: 2 case reports
Reactions Weekly, 2014, 1507 (1) : 9 - 9
[50] Amikacin/carbapenems/piperacillin/tazobactamTreatment failure: 2 case reports
Reactions Weekly, 2025, 2053 (1) : 25 - 25

← 1 2 3 4 5 →